Should You Hold Your Stake in Perrigo Company, plc (PRGO)?
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Contrarian Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Perrigo Co Plc (PRGO)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 3,167,976 | $70,550,826 | +280% | 0.03% |
| 2. | Diamond Hill Capital Ric Dillon | 1,797,746 | $40,035,803 | +9% | 0.19% |
| 3. | Ion Asset Management Stephen Levey And Jonathan Half | 1,760,000 | $39,195,200 | -54% | 4.3% |
| 4. | GAMCO Investors Mario Gabelli | 855,498 | $19,051,940 | -5% | 0.18% |
| 5. | Blue Door Asset Management Michael Luddy And Daniel Krausz | 576,725 | $12,843,666 | -35% | 6.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.18 | 7,500 | $106,350.00 | 17,375 | 2025-11-12 | Filing | |
| $22.41 | 1,255 | $28,124.55 | 1,255 | 2025-09-08 | Filing | |
| $23.20 | 1,000 | $23,200.00 | 1,000 | 2025-09-05 | Filing | |
| $24.10 | 1,488 | $35,857.82 | 41,939 | 2025-08-22 | Filing | |
| $22.97 | 4,375 | $100,497.25 | 9,875 | 2025-08-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.44 | 7,800 | $214,032.00 | 33,666 | 2025-03-10 | Filing | |
| $28.27 | 17,598 | $497,495.46 | 5,409 | 2024-12-09 | Filing | |
| $27.30 | 8,954 | $244,444.20 | 6,009 | 2024-09-13 | Filing | |
| $29.40 | 13,000 | $382,245.50 | 20,553 | 2024-08-26 | Filing | |
| $27.43 | 6,683 | $183,281.28 | 7,000 | 2024-08-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,882,215 | $309,156,928 | 0% | |
| 2. | 13,475,683 | $300,103,462 | 0.01% | |
| 3. | 7,695,238 | $171,366,629 | 0.04% | |
| 4. | 6,902,996 | $153,730,644 | 0.01% | |
| 5. | 5,727,917 | $127,560,711 | 0.09% |
News See All
Canaccord Maintains Buy on Perrigo (PRGO) While Cutting Price Target to $20
On November 6, Canaccord lowered its price target on Perrigo Company plc (NYSE:PRGO) to $20 from $40, while maintaining a Buy rating on the stock, as reported by The Fly.
15 Best 52-Week Low Dividend Stocks to Invest In
Dividend stocks have traditionally attracted long-term investors, but they are often overshadowed by flashy growth stocks in terms of popularity.
Perrigo (PRGO) Falls to 52-Week Low on Weak Sales, Infant Formula Review
Perrigo fell to a new 52-week low on Wednesday, extending to a three-day losing streak, as investor sentiment was dampened by weak net sales and news that it was conducting a strategic review of its infant...
Perrigo Company plc (NYSE:PRGO) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Perrigo Q3 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 5, 2025.
Solid Dividend Yield and 22 Years of Growth Highlight Perrigo’s (PRGO) Investor Appeal
Perrigo Company plc (NYSE:PRGO) is a global consumer self-care company best known for its broad range of over-the-counter (OTC) health and wellness products.
12 Best Dividend Stocks With Yields Above 4%
Investors often keep a close eye on the stock market, tracking price movements and hoping for gains.
Perrigo Company plc (PRGO) Reports $1.06B Q2 Sales, Advances ‘Three-S’ Strategy
Perrigo Company plc (NYSE:PRGO), a global leader in consumer self-care products, is sharpening its focus on high-growth, high-margin categories across North America and Europe, and it stands thirteenth...
13 Most Oversold Healthcare Stocks So Far in 2025
The healthcare innovation landscape in 2025 is navigating a complex mix of challenges and opportunities, marked by contrasting trends in fundraising, investment, and technology adoption.
Perrigo Company plc (PRGO) Sells Dermacosmetics Unit in €327M Deal
Perrigo Company plc (NYSE:PRGO), a global healthcare supplier, specializes in over-the-counter (OTC) and self-care products, generic prescription pharmaceuticals, and active pharmaceutical ingredients...
Hedge Fund Resource Center Billionaire Hedge Funds
